EMBO Young Investigator Programme
Julian Stingele named as EMBO Young Investigator
Julian Stingele, Professor for Cellular Biochemistry at the LMU Gene Center since 2017, has been selected as EMBO Young Investigator.
Through the Young Investigator Programme, EMBO identifies and supports some of the best young researchers in the life sciences. EMBO is an organization of more than 1800 leading researchers that promotes excellence in the life sciences in Europe and beyond. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.
EMBO Young Investigators are under the age of 40, within their first four years of being principal investigators, and have a proven record of scientific excellence. As part of the Young Investigator Programme they have access to a wide range of benefits including networking opportunities, training in leadership skills and responsible research practices, and access to core facilities at the European Molecular Biology Laboratory (EMBL). Young Investigators receive an award of 15,000 euros in the second year of their tenure, and can apply for further funding, travel grants and take advantage of mentorship opportunities amongst many other benefits.
Julian is an expert in genome maintenance. His work focusses on the cellular mechanisms that resolve DNA-protein crosslinks and restore replication of damaged DNA. The results of his research help us understand cancer development and cellular ageing and may one day contribute to make chemotherapies more effective. Before establishing his own group at the Gene Center in 2017, Julian worked with Stefan Jentsch at the MPI for Biochemistry in Martinsried and with Simon Boulton at the Francis Crick Institute in London.
For more information about Julian Stingele's career and his research projects, please visit the Stingele lab website.
Please visit the EMBO website for more information about EMBO and read its press release.